Stem Cells in Epithelial Tissues

Rcjohnsen rcjohnsen at aol.com
Sat Mar 4 20:31:24 EST 2000


                                                                          
                                                                          
                                                                          
                                                        Stem Cells in
Epithelial Tissues 

J. M. W. Slack 

    Most, if not all, epithelial tissues contain stem cells. They are
responsible for normal tissue renewal or for regeneration following damage. Our
present knowledge of their properties is limited and is mainly derived from
studies of cell kinetics and from clonal analysis. 
Developmental Biology Programme, Department of Biology and Biochemistry,
University of Bath, Bath BA2 7AY, UK. E-mail: j.m.w.slack at bath.ac.uk 

    About 60% of the differentiated tissue types in a mammalian body are
epithelia (1). The range of their functions is vast and frequently involves the
secretion of bioactive materials and absorption of substances as well as the
mechanical integrity of surfaces. How epithelia are formed and maintained is
one of the key problems of developmental biology and an area in which many
basic questions remain unsolved. Some epithelia, such as the skin or intestine,
show rapid cell turnover (2, 3), whereas others, such as the liver or pancreas,
show a very slow turnover under normal conditions but with special adaptations
for regeneration (4-6).  
    So all epithelia will probably prove to contain cells that are capable of
repopulating them, either during normal life or at least under circumstances of
tissue repair. Various definitions for a "stem cell" have been adopted by
different authors, but a consensus definition is likely to include at least two
ideas: stem cells are able to reproduce themselves throughout the life-span of
the animal, and they are able to give rise to differentiated cells (7). To this
is often added the idea that stem cells are visibly undifferentiated. However,
this would exclude some populations that are often described as stem cells,
such as cells of the basal epidermal layer or those of the pancreatic and bile
ducts. Stem cells are also often thought to undergo obligatory asymmetric
division to yield one stem cell daughter and one daughter destined to
differentiate. This may be true in some situations, but it is not a necessary
attribute because the population of stem cells can still be self-maintaining
when some divisions yield two stem cell daughters and others yield two
differentiating daughters. 

Commitment of Stem Cells

    With certain exceptions that will be discussed below, epithelial stem cells
are considered to be developmentally committed such that they can form the
differentiated cells of their own particular tissue type but not those of any
other. In studies on early development, we are now accustomed to the idea that
developmental commitment is encoded as a combination of transcription factors
(8). The same is presumably true for epithelial stem cells, but because of
their relative inaccessibility and the difficulty of isolating them for
experimentation, there is currently no type that can be characterized by its
transcription factor combination.  
    Cell division is not, in itself, an indication of stem cell status. Cell
kinetic studies have shown that stem cells are usually slowly dividing and that
most of the dividing cells in a tissue are "transit amplifying cells" that are
committed to differentiate after a finite number of divisions (2, 9). The
presence of the transit amplifying cells means that the tissue can maintain a
high output of differentiated cells from a small number of stem cells. 
    There is some characterization for epidermal stem cells, which have been
shown to carry higher levels of certain cell adhesion molecules on their
surfaces and also to contain a higher level of -catenin (10-12). In the hair
follicle, cytokeratin 15 has been reported as a stem cell marker (13). In the
small intestine, knockout mice for TCF4 fail to form a proliferative
compartment (14). TCF4 is a high mobility group-box transcription factor that
normally associates with -catenin in response to Wnt signaling, so it may be
important that these elements of the Wnt pathway have been found playing a role
in two different types of stem cell.  

Structural-Proliferative Units

    In the traditional renewing cell population, there is a clear relation
between the activity of the stem cells and the histological structure of the
tissue. The dividing cells are located in one place, and the differentiated
cells lie elsewhere. For example, in the intestinal crypt, the stem cells are
present near the crypt base, the transit amplifying cells occupy perhaps
two-thirds of the height of the crypt, and the postmitotic differentiated cells
line the upper part of the crypts and the villi (2). The histological structure
of most other epithelia is also clearly composed of structural units (for
example, the glands of the stomach, the acini of the salivary glands, the
lobules of the liver, and the nephrons of the kidney). Although good evidence
is largely lacking, it is attractive to regard these structures also as units
of cell renewal, in other words, to consider each visible histological unit as
a "structural-proliferative unit" composed of one or a few stem cells feeding a
differentiated compartment [(9) and Fig. 1]. 

    Evidence for this concept comes from studies of the clonal makeup of
epithelia, and the best analyzed case is that of the small intestine. There
have been two main types of study. The first used aggregation chimeras, which
are mice formed by the aggregation of two embryos at the preimplantation stage.
The cells from the two embryos become well mixed and cooperate to form one
single mouse of normal size and normal proportions. If the two embryos differ
in the expression of some genetic marker, then it is possible to visualize the
clonal composition of the tissues. Intestinal crypts are polyclonal at the time
of formation and become monoclonal 1 to 2 weeks after birth (15-17). This does
not mean, as initially supposed, that there is just one stem cell per crypt,
because the genetic diversity of the stem cells may become progressively
reduced both by division of the crypt (18) and by the differentiation of both
progeny of a stem cell (19). The second method is mutagenesis to produce a
visible cell label. Early experiments again showed monoclonal mutant crypts
(20-22) but were hampered by problems of clone visualization. Recent work with
a positive label in the mutant clone suggests that there are four to five stem
cells per crypt (23).  

 
Fig. 1. Structural-proliferative units. In this model of tissue organization,
each glandular structure is maintained by slow cellular turnover. There is a
"niche" defined by interactions with the stromal tissue, which maintains one or
a few cells as stem cells. The progeny of the stem cells will move around the
gland such that the oldest cells are removed by apoptosis at the opposite
extremity. [View Larger Version of this Image (23K GIF file)] 

    To what extent other epithelia are organized as structural-proliferative
units is not yet clear because the drift to monoclonality will be slow where
cell turnover is low (24). Gastric glands do follow the rule (25); there has
been some controversy about the liver (26, 27); and in the epidermis, the hair
follicles probably are self-contained structural-proliferative units, but the
main area of epidermis between the hair follicles is not divided into obvious
structures (28, 29).  

Multi- and Unipotency

    Epithelia are usually composed of several distinct cell types, and the
ability to form all of them, or "multipotency," is often considered to be an
aspect of stem cell behavior. The evidence for multipotency is good although
usually derived from situations of severe tissue damage. For example, in the
small intestine, there are four classes of mature differentiated cells
(absorptive, goblet, Paneth, and enteroendocrine cells). The concept of a
multipotent stem cell producing all four types was proposed by Cheng and
Leblond (30), who followed radiolabeled phagosomes derived from [3H]thymidine
labeling from the cells of the crypt base into the differentiated populations.
Although it did identify the stem cell region, this work did not prove the
existence of multipotent cells. Bipotent (absorptive and goblet) cells have
recently been detected by mutagenesis (23). Evidence for multipotent cells has
been obtained from the use of doses of radiation sufficient to destroy most of
the cells, which is followed by regeneration from isolated foci. These were
shown to be monoclonal because they consist of just one genotype when examined
for X-linked markers in heterozygous females (31). Each monoclonal focus can
produce at least three of the cell types, although the animals did not survive
long enough for the production of Paneth cells. Although this result is
unambiguous, the degree of tissue damage produced by the radiation is enormous,
so it may not reflect the situation of normal cell turnover.  
    Multipotent stem cells would presumably resemble the original embryonic
rudiment for the tissue in question, which will produce the appropriate mixture
of cell types in the course of normal development. For example, the embryonic
epidermis forms both stratified epidermis and hair follicles (32), the
embryonic liver hepatoblasts form both hepatocytes and bile duct cells (33,
34), and the embryonic pancreatic epithelium forms both exocrine and endocrine
cell types (35).  
    Despite the undoubted existence of some cells that can show multipotent
behavior following tissue damage, there is also evidence that, where tissue
damage is low or nonexistent, most stem cells are unipotent, producing just one
type of differentiated cell. I am here assuming that the definition of "stem
cell" can accommodate unipotent as well as multipotent cells. For example, in
the liver, regeneration in postnatal life normally proceeds from the
hepatocytes (36), but if hepatocyte division is inhibited, it can occur from
ductular oval cells instead (4). In the pancreas, the normal slow cellular
turnover in adult life is probably due to intrinsic growth of endocrine and
exocrine compartments separately (6). But in abnormal circumstances, such as
transgenic mice expressing interferon- in the pancreas, de novo formation of
islets and acini can occur from ducts (37, 38). Finally, the recent mutagenesis
study of the small intestine suggests that 80 to 90% of long-lived mutant
clones are unipotent, forming either absorptive or goblet cells, whereas only
10 to 20% are multipotent (23). 
    All of these examples suggest that steady state cell renewal occurs largely
from unipotent stem cells, whereas tissue regeneration following damage may
also occur from multipotent stem cells. This suggests that, when regeneration
is required, there must be local chemical signals released in tissues, which
can activate the dormant multipotent cells. The identification of these signals
is potentially of considerable clinical importance, but we know little about
them at present. Intriguingly, the overexpression of a stabilized version of
-catenin in the epidermis has been shown to cause the de novo formation of hair
follicles (39), further evidence for an involvement of the Wnt pathway in the
regulation of stem cell behavior. 

Metaplasia

    Whether multi- or unipotent, most of the time a stem cell will continue to
generate the characteristic cell types for its own tissue. Occasionally, and
again almost always in association with tissue damage and regeneration, there
are errors leading to metaplasia. This is the formation of one differentiated
cell type from another in postnatal life, and it happens because one or a few
stem cells change their state of developmental commitment. In the embryo,
tissues that develop as neighboring rudiments in a common cell sheet will have
similar combinations of transcription factors defining their commitment and may
differ by the expression of just one transcription factor gene. Assuming that
stem cells are indeed the same as the original embryonic progenitors for the
tissue, then a change of state of such a gene in later life would cause the
stem cells to "flip" from producing one tissue to producing another (Fig. 2). 

    Metaplasias in epithelia are not uncommon and do in fact often consist of a
conversion of a patch of tissue into another type that arose as an adjacent
rudiment in the embryo (40). For example, patches of ectopic intestinal
epithelium are found in the stomach (41), colonic type epithelium in the
urinary bladder (42), endocervical epithelium in the vagina (43), or foci of
hepatocytes in the regenerating pancreas (44). 
    It is of interest to inquire whether these metaplasias arise from somatic
mutation of the genes encoding their commitment or from an epigenetic process
that activates or represses the same genes. One approach to this, following the
lead of cancer research (45), is to inquire whether or not foci of metaplasia
are monoclonal. This can be done by examining their composition in mosaic
animals that are composed of a mixture of cells of different genotypes. A
recent study of intestinal metaplasia showed that foci were polyclonal and must
therefore arise from more than one cell (46). So, the mechanism in this case is
unlikely to be mutation and more likely to be an epigenetic change. Further
studies of other types of metaplastic foci will be needed to find whether this
is a general rule.  

 Wider Plasticity of Stem Cells?

    The existence of epithelial metaplasias is evidence for some plasticity of
stem cells. A more dramatic type of reprogramming is suggested by some recent
experiments on the grafting of bone marrow cells between individuals. It has
recently been shown that genetically marked bone marrow can contribute to the
regeneration of skeletal muscle (47) and of liver (48) in the host animals. In
one study, the graft was composed of purified hemopoietic stem cells (49).
Although the frequency of labeled foci is small and the time for their
development is long, this is still remarkable because it implies a much more
extreme reprogramming of developmental commitment than that found in endogenous
metaplasias. The experiments involve the injection of
  
Fig. 2. Metaplasia. In the embryo, two tissue types arise from a common cell
sheet because a gene X is activated in one tissue but not in the other. If
something later turns this gene off in one or a few stem cells of the tissue,
then a metaplasia will result. 

suspensions of cells, so single graft cells are likely to end up completely
surrounded by cells of a foreign tissue. In embryological experiments, isolated
single cells often show more developmental lability than extended masses of
tissue (50, 51), so perhaps this should be expected in the adult animal as
well.  
    The results of such experiments should not confuse us by suggesting that
all types of stem cell are the same. The well-characterized hematopoietic stem
cell is clearly quite distinct from the equally well studied early embryonic
stem cell and probably equally distinct from the epithelial stem cells of the
various differentiated tissue types. However, they do show that there is
considerable potential scope for reprogramming epithelial stem cells by changes
to their environment. 
    The existence of endogenous processes of tissue repair in many or most
epithelia suggests that there is a whole unexplored area of potentially novel
therapies based on the stimulation of these regenerative mechanisms. Progress
will require better characterization of epithelial stem cells in terms of
molecular markers. It will also require the establishment of more in vitro
culture systems, like those used for epidermis (3, 52), in which the control of
stem cell behavior can be investigated in detail. Perhaps the most important
advance will be the identification of the mysterious environmental factors that
control stem cell behavior, both with regard to self-renewal potential and to
the ability to form particular types of differentiated cells.  

REFERENCES AND NOTES


1.	B. Alberts et al., Eds., in The Molecular Biology of the Cell (Garland,
New York, 1994), pp. 1138-1193. 
2.	C. S. Potten and M. Loeffler, Development 110, 1001 (1990) [ISI]
[Medline]. 
3.	F. M. Watt, Philos. Trans. R. Soc. London Ser. B 353, 831 (1998) [ISI]
[Medline]. 
4.	M. Alison, et al., J. Hepatol. 26, 343 (1997) [ISI] [Medline]. 
5.	J. M. W. Slack, Development 121, 1569 (1995) [ISI] [Medline]. 
6.	D. T. Finegood, L. Scaglia, S. Bonner-Weir, Diabetes 44, 249 (1995)
[ISI] [Medline]. 
7.	L. G. Lathja, in Stem Cells, C. S. Potten, Ed. (Churchill Livingstone,
Edinburgh, 1983), pp. 1-11. 
8.	L. Wolpert, Principles of Development (Oxford Univ. Press, Oxford,
1998). 
9.	C. S. Potten, in Stem Cells and Tissue Homeostasis, B. I. Lord,
C. S. Potten, R. J. Cole, Eds. (Cambridge Univ. Press, Cambridge, 1978), pp.
317-334. 
10.	P. H. Jones and F. M. Watt, Cell 73, 713 (1993) [ISI] [Medline]. 
11.	A. Li, P. J. Simmons, P. Kaur, Proc. Natl. Acad. Sci. U.S.A. 95, 3902
(1998) [ISI] [Abstract/Full Text]. 
12.	A. J. Zhu and F. M. Watt, Development 126, 2285 (1999) [ISI] [Medline].

13.	S. Lyle, et al., J. Cell Sci. 111, 3179 (1998) [ISI] [Medline]. 
14.	V. Korinek, et al., Nature Genet. 19, 379 (1998) [ISI] [Medline]. 
15.	G. H. Schmidt, D. J. Winton, B. A. J. Ponder, Development 103, 785
(1988) [ISI] [Medline]. 
16.	K. A. Roth, M. L. Hermiston, J. I. Gordon, Proc. Natl. Acad. Sci.
U.S.A. 88, 9407 (1991) [ISI] [Abstract]. 
17.	M. L. Hermiston and J. I. Gordon, Am. J. Physiol. 268, G813 (1995)
[Medline]. 
18.	H. Cheng and M. Bjerknes, Anat. Rec. 211, 420 (1985) [ISI] [Medline]. 
19.	M. Loeffler, A. Birke, D. Winton, C. S. Potten, J. Theor. Biol. 160,
471 (1993) [ISI] [Medline]. 
20.	D. F. R. Griffiths, S. J. Davies, D. Williams, G. T. Williams, E. D.
Williams, Nature 333, 461 (1988) [ISI] [Medline]. 
21.	D. J. Winton, M. A. Blount, B. A. J. Ponder, Nature 333, 463 (1988)
[ISI] [Medline]. 
22.	J. I. Gordon, G. H. Schmidt, K. A. Roth, FASEB J. 6, 3039 (1992) [ISI]
[Abstract]. 
23.	M. Bjerknes and H. Cheng, Gastroenterology 116, 7 (1999) [ISI] . 
24.	M. Kusakabe, et al., J Cell Biol. 107, 257 (1988) [ISI] [Abstract]. 
25.	S. Nomura, H. Esumi, C. Job, S. S. Tan, Dev. Biol. 204, 124 (1998)
[ISI] [Medline]. 
26.	S. H. Sigal, S. Brill, A. S. Fiorino, L. M. Reid, Am. J. Physiol. 263,
G139 (1992) [ISI] [Medline]. 
27.	M. Alison, M. Golding, E. N. Lalani, C. Sarraf, Philos. Trans. R. Soc.
London Ser. B 353, 877 (1998) [ISI] [Medline]. 
28.	G. H. Schmidt, M. A. Blount, B. A. J. Ponder, Development 100, 535
(1987) [ISI] [Medline]. 
29.	U. B. Jensen, S. Lowell, F. M. Watt, Development 126, 2409 (1999) [ISI]
[Medline]. 
30.	H. Cheng and C. P. Leblond, Am. J. Anat. 141, 537 (1974) [ISI]
[Medline]. 
31.	M. Inoue, et al., Am. J. Pathol. 132, 49 (1988) [ISI] [Medline]. 
32.	P. Sengel, The Morphogenesis of Skin (Cambridge Univ. Press, Cambridge,
1976). 
33.	N. Shiojiri, J. M. Lemire, N. Fausto, Cancer Res. 51, 2611 (1991) [ISI]
[Medline]. 
34.	S. S. Thorgeirsson, Am. J. Pathol. 142, 1331 (1993) [ISI] [Medline]. 
35.	A. C. Percival and J. M. W. Slack, Exp. Cell Res. 247, 123 (1999) [ISI]
[Medline]. 
36.	G. K. Michalopoulos and M. C. DeFrances, Science 276, 60 (1997) [ISI]
[Abstract/Full Text]. 
37.	L. Rosenberg, R. A. Brown, W. P. Duguid, J. Surg. Res. 35, 63 (1983)
[ISI] [Medline]. 
38.	D. Gu and N. Sarvetnick, Development 118, 33 (1993) [ISI] [Medline]. 
39.	U. Gat, R. DasGupta, L. Degenstein, E. Fuchs, Cell 95, 605 (1998) [ISI]
[Medline]. 
40.	J. M. W. Slack, J. Theor. Biol. 114, 463 (1985) [ISI] [Medline]. 
41.	N. Matsukura, et al., J. Natl. Cancer Inst. 65, 231 (1980) [ISI]
[Medline]. 
42.	A. M. Ward, Virchows Arch. Abt. A Pathol. Anat. 352, 296 (1971) [ISI]
[Medline]. 
43.	D. A. Antonioli and L. Burke, Am. J. Clin. Pathol. 64, 625 (1975) [ISI]
[Medline]. 
44.	M. S. Rao, et al., Am. J. Pathol. 134, 1069 (1989) [ISI] [Medline]. 
45.	J. S. Wainscoat and M. F. Fey, Cancer Res. 50, 1355 (1990) [ISI]
[Medline]. 
46.	S. Nomura, M. Kaminishi, K. Sugiyama, T. Oohara, H. Esumi, Gut 42, 663
(1998) [ISI] [Abstract/Full Text]. 
47.	G. Ferrari, et al., Science 279, 1528 (1998) [ISI] [Abstract/Full
Text]. 
48.	B. E. Petersen, et al., Science 284, 1168 (1999) [ISI] [Abstract/Full
Text]. 
49.	E. Gussoni, et al., Nature 401, 390 (1999) [ISI] [Medline]. 
50.	D. Forman and J. M. W. Slack, Nature 286, 492 (1980) [ISI] [Medline]. 
51.	J. B. Gurdon, Nature 336, 772 (1988) [ISI] [Medline]. 
52.	R. H. Whitehead, K. Demmler, S. P. Rockman, N. K. Watson,
Gastroenterology 117, 858 (1999) [ISI] . 
53.	I thank D. Tosh and F. Watt for comments on drafts. This work was
supported by the Medical Research Council, grant G9520375. 


Volume 287, Number 5457 Issue of 25 Feb 2000, pp. 1431 - 1433 
©2000 by The American Association for the Advancement of Science. 

Copyright © 2000 by the American Association for the Advancement of Science.   




More information about the Cellbiol mailing list